Ironwood Pharmaceuticals (IRWD) Other Non Operating Income (2011 - 2026)

Ironwood Pharmaceuticals has disclosed Other Non Operating Income across 12 years of filings, most recently posting $42000.0 for Q2 2026.

• In Q2 2026, Other Non Operating Income rose 7.69% year-over-year to $42000.0; the TTM figure through Jun 2026 stood at $694000.0 (down 99.26% YoY), while the FY2025 annual figure was $686000.0, down 91.54% from the prior year.
• Other Non Operating Income came in at $42000.0 for Q2 2026 at Ironwood Pharmaceuticals, roughly flat from $42000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $93.4 million in Q4 2023 to a low of -$681000.0 in Q2 2022.
• Average Other Non Operating Income over 4 years is $7.9 million, with a median of $42000.0 recorded in 2026.
• The largest YoY upside for Other Non Operating Income was 179467.31% in 2023 against a maximum downside of 97.4% in 2023.
• Over 4 years, Other Non Operating Income stood at $52000.0 in 2022, then soared by 179467.31% to $93.4 million in 2023, then plunged by 99.39% to $570000.0 in 2025, then plunged by 92.63% to $42000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $42000.0 in Q2 2026, $42000.0 in Q1 2026, and $570000.0 in Q4 2025.